Riskpilot← Back to searchSign inGet full accessPharmetheus Holding AB
ABDissolvedOrg 5590384938Economic activity was not specified by tax authority · NACE 0000Est. 20150 employees
Revenue 2022
SEK 0
EBITDA margin
—
+10% vs 2021
Equity ratio
71.7%
Financial strength
Net profit 2022
SEK 19,6M
+78% vs 2021
| Revenue | SEK 0 | — |
| EBITDA | SEK -28K | +10% |
| Net profit | SEK 19,6M | +78% |
| Total assets | SEK 61,3M | +18% |
| Equity | SEK 44M | +40% |
| Employees | 0 | — |
Legal name
Pharmetheus Holding AB
Org number
5590384938
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
2 december 2015
Share capital
SEK 55 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-11-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall äga och förvalta aktier i dotter- och intresse- bolag, förvalta värdepapper och fast och lös egendom, direkt eller indirekt bedriva konsult- och analystjänster inom läkemedels- och bioteknikbranschen, utveckling av modeller och programvara för samma område samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | −20 | −17 | −27 | −17 | −23 | −31 | −28 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −20 | −17 | −27 | −17 | −23 | −31 | −28 |
| Net financials | 5 628 | 1 383 | 8 184 | 6 789 | 10 345 | 10 642 | 19 074 |
| Profit before tax | 5 608 | 2 775 | 8 807 | 7 200 | 10 718 | 11 001 | 19 600 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 5 608 | 2 775 | 8 807 | 7 200 | 10 718 | 11 001 | 19 600 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Total assets | 45 855 | 43 055 | 46 176 | 47 276 | 51 924 | 52 097 | 61 343 |
| Equity | 5 663 | 6 788 | 13 945 | 19 254 | 26 772 | 31 374 | 43 970 |
| Long-term debt | 35 550 | 34 560 | 27 650 | 23 700 | 19 750 | 15 800 | 11 850 |
| Short-term debt | 4 642 | 1 707 | 4 581 | 4 322 | 5 401 | 4 923 | 5 523 |
| Total debt | 40 192 | 36 267 | 32 231 | 28 022 | 25 151 | 20 723 | 17 373 |
EBITDA margin
-2800000.0%
This company
15.8%
Market median
-17721619% vs market
20162022
Equity ratio
71.7%
This company
38.2%
Market median
+88% vs market
20162022
Return on equity
44.6%
This company
18.4%
Market median
+142% vs market
20162022
Net profit margin
1960000000.0%
This company
8.1%
Market median
+24197530764% vs market
20162022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162022
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20162022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-11-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-11-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-12-01 – 2019-11-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-12-01 – 2018-11-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-12-01 – 2017-11-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-12-01 – 2016-11-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BM Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
JK | Audit | 2019 | — | — |
PA Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
EM Auditor Substitute | Auditor Substitute | 2022 | — | — |
JE Chief Auditor | Chief Auditor | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
New Pharmetheus Holding AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
New Pharmetheus Holding AB
Pharmetheus Holding AB Board members of Pharmetheus Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birgitta Marie Sandström | Chief Executive Officer | 0 companies |
| Johanna Katarina Boive | Audit | 0 companies |
| Peter Andrew Miligan | Chief Executive Officer | 0 companies |
| Eva Maria Andersson Dverstorp | Auditor Substitute | 0 companies |
| Johan Erik Niclas Bergenmo | Chief Auditor | 0 companies |
| Jan Per Martin Bergstrand | Board of Directors | 0 companies |
| Karl Joakim Nyberg | Board of Directors | 0 companies |
| Sofia Helena Friberg Hietala | Deputy Board Member | 0 companies |
| Mats Olof Karlsson | Chairman | 0 companies |
| Agneta Ingegerd Franksson | Board of Directors | 0 companies |
| Fredrik Veimar Alpsten | Board of Directors | 0 companies |